SCYNEXIS Reports Full Year 2024 Financial Results and Provides Corporate Update
The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in ...
Basilea Pharmaceutica AG: Strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
The Indian Express3d
Warning signs of kidney fungus you shouldn’t ignore (especially if you’re diabetic)
often caused by the fungus Mucor, also known as black fungus.” In extreme scenarios, infections can lead to dangerously low blood pressure, requiring ICU care and even being life-threatening. Timely ...
Nasdaq4d
SCYNEXIS, Inc. Advances Phase 1 Trial of SCY-247 Antifungal and Prepares for Phase 3 MARIO Study Restart
SCY-247 is a second-generation antifungal with potential against multi-drug-resistant fungal infections ... 11th Advances Against Aspergillosis and Mucormycosis (AAAM) Conference.
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Morningstar2d
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced ...
Nature4d
Meningitis articles from across Nature Portfolio
Meningitis is an inflammatory disorder that is caused by infection of the meninges the protective membranes that surround the central nervous system. Meningitis can be caused by bacterial or ...